BioSpace - Print News Article

Pivotal BioSciences, Inc. And ProteomTech, Inc. Announce Collaboration 10/19/2005 5:11:12 PM Pivotal BioSciences, Inc., a privately-held Los Angeles-based biotechnology company, and ProteomTech, Inc., a privately-held Emeryville-based company, today announced their collaboration for the development of PB1, Pivotal's mutant IL-2 cancer therapeutic.

Pivotal BioSciences, Inc. And ProteomTech, Inc. Announce Collaboration
10/19/2005 5:11:12 PM

Pivotal BioSciences, Inc., a privately-held Los Angeles-based biotechnology company, and ProteomTech, Inc., a privately-held Emeryville-based company, today announced their collaboration for the development of PB1, Pivotal's mutant IL-2 cancer therapeutic.